Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tami L Bair

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Circulation|January 23, 2003
Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary diseaseBenjamin D Horne, Joseph B Muhlestein, John F Carlquist, et al.
The American Journal of Cardiology|November 3, 2004
Early effects of statins in patients with coronary artery disease and high C-reactive proteinJoseph B Muhlestein, Jeffrey L Anderson, Benjamin D Horne, et al.
American Heart Journal|August 13, 2011
Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?Jeffrey L Anderson, Ryan C Vanwoerkom, Benjamin D Horne, et al.
American Heart Journal|December 9, 2003
The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery diseaseJohn F Carlquist, Joseph B Muhlestein, Benjamin D Horne, et al.
The American Journal of Medicine|October 27, 2004
Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery diseaseLillian L C Khor, Joseph B Muhlestein, John F Carlquist, et al.
Journal of Clinical Medicine|January 8, 2023
Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare ExperienceJeffrey L Anderson, Stacey Knight, Heidi T May, et al.
Nutrients|July 13, 2024
Periodic Fasting and Acute Cardiac Events in Patients Evaluated for COVID-19: An Observational Prospective Cohort StudyBenjamin D Horne, Jeffrey L Anderson, Francois Haddad, et al.
American Heart Journal|May 9, 2026
CorCal Outcomes: a Randomized Trial using the Pooled Cohort Equation or Coronary Artery Calcium to Select Statin Therapy in Primary Prevention Patients. Study Design and Baseline CharacteristicsJeffrey L Anderson, Heidi T May, Tyler Winslow, et al.
Psychology, Health & Medicine|January 24, 2017
The association of antidepressant and statin use with death and incident cardiovascular disease varies by depression severityHeidi T May, Tami L Bair, Brenda Reiss-Brennan, et al.
BMC Primary Care|April 2, 2022
Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysisJoseph B Muhlestein, Jennifer Kammerer, Tami L Bair, et al.
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Circulation|January 23, 2003
Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary diseaseBenjamin D Horne, Joseph B Muhlestein, John F Carlquist, et al.
The American Journal of Cardiology|November 3, 2004
Early effects of statins in patients with coronary artery disease and high C-reactive proteinJoseph B Muhlestein, Jeffrey L Anderson, Benjamin D Horne, et al.
American Heart Journal|August 13, 2011
Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?Jeffrey L Anderson, Ryan C Vanwoerkom, Benjamin D Horne, et al.
American Heart Journal|December 9, 2003
The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery diseaseJohn F Carlquist, Joseph B Muhlestein, Benjamin D Horne, et al.
The American Journal of Medicine|October 27, 2004
Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery diseaseLillian L C Khor, Joseph B Muhlestein, John F Carlquist, et al.
Journal of Clinical Medicine|January 8, 2023
Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare ExperienceJeffrey L Anderson, Stacey Knight, Heidi T May, et al.
Nutrients|July 13, 2024
Periodic Fasting and Acute Cardiac Events in Patients Evaluated for COVID-19: An Observational Prospective Cohort StudyBenjamin D Horne, Jeffrey L Anderson, Francois Haddad, et al.
American Heart Journal|May 9, 2026
CorCal Outcomes: a Randomized Trial using the Pooled Cohort Equation or Coronary Artery Calcium to Select Statin Therapy in Primary Prevention Patients. Study Design and Baseline CharacteristicsJeffrey L Anderson, Heidi T May, Tyler Winslow, et al.
Psychology, Health & Medicine|January 24, 2017
The association of antidepressant and statin use with death and incident cardiovascular disease varies by depression severityHeidi T May, Tami L Bair, Brenda Reiss-Brennan, et al.
BMC Primary Care|April 2, 2022
Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysisJoseph B Muhlestein, Jennifer Kammerer, Tami L Bair, et al.
Pageof 14